Millennium Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-585,406
| Closed | -$1.99M | – | 3925 |
|
|
2018
Q3 | $1.99M | Sell |
585,406
-141,718
| -19% | -$482K | ﹤0.01% | 2151 |
|
|
2018
Q2 | $2.73M | Sell |
727,124
-213,465
| -23% | -$803K | ﹤0.01% | 1949 |
|
|
2018
Q1 | $3.85M | Buy |
+940,589
| New | +$3.85M | 0.01% | 1830 |
|
|
2017
Q4 | – | Sell |
-1,444,625
| Closed | -$10.3M | – | 3893 |
|
|
2017
Q3 | $10.3M | Sell |
1,444,625
-411,214
| -22% | -$2.92M | 0.02% | 1148 |
|
|
2017
Q2 | $13.4M | Buy |
1,855,839
+581,419
| +46% | +$4.2M | 0.02% | 829 |
|
|
2017
Q1 | $7.85M | Buy |
1,274,420
+417,186
| +49% | +$2.57M | 0.01% | 1079 |
|
|
2016
Q4 | $5.02M | Buy |
857,234
+599,504
| +233% | +$3.51M | 0.01% | 1242 |
|
|
2016
Q3 | $1.37M | Sell |
257,730
-713,074
| -73% | -$3.79M | ﹤0.01% | 1938 |
|
|
2016
Q2 | $6.43M | Buy |
970,804
+661,757
| +214% | +$4.38M | 0.01% | 1041 |
|
|
2016
Q1 | $1.44M | Sell |
309,047
-632,287
| -67% | -$2.95M | ﹤0.01% | 1795 |
|
|
2015
Q4 | $4.75M | Buy |
941,334
+901,827
| +2,283% | +$4.55M | 0.01% | 1289 |
|
|
2015
Q3 | $139K | Sell |
39,507
-601,941
| -94% | -$2.12M | ﹤0.01% | 3004 |
|
|
2015
Q2 | $6.4M | Buy |
641,448
+425,646
| +197% | +$4.25M | 0.01% | 1161 |
|
|
2015
Q1 | $2.75M | Buy |
215,802
+150,461
| +230% | +$1.92M | 0.01% | 1635 |
|
|
2014
Q4 | $925K | Buy |
+65,341
| New | +$925K | ﹤0.01% | 2214 |
|
|
2014
Q3 | – | Sell |
-39,565
| Closed | -$609K | – | 3262 |
|
|
2014
Q2 | $609K | Buy |
39,565
+20,509
| +108% | +$316K | ﹤0.01% | 2109 |
|
|
2014
Q1 | $325K | Sell |
19,056
-208,614
| -92% | -$3.56M | ﹤0.01% | 2282 |
|
|
2013
Q4 | $2.95M | Sell |
227,670
-152,693
| -40% | -$1.98M | 0.01% | 1237 |
|
|
2013
Q3 | $3.84M | Sell |
380,363
-735,651
| -66% | -$7.42M | 0.01% | 1024 |
|
|
2013
Q2 | $8.34M | Buy |
+1,116,014
| New | +$8.34M | 0.03% | 625 |
|